
検索結果 11258 件
| JaLCDOI | 10.18926/AMO/30755 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Taira, Naruto| Doihara, Hiroyoshi| Oota, Tetsuya| Hara, Fumikata| Shien, Tadahiko| Takahashi, Hirotoshi| Yoshitomi, Seiji| Ishibe, Youichi| Shimizu, Nobuyoshi| |
| 抄録 | Human esophageal cancers have been shown to express high levels of epidermal growth factor receptor (EGFR) and a relationship between high EGFR expression and local advance, the number of lymph node metastases, life expectancy, and sensitivity to chemo-radiotherapy has been demonstrated. We examined the use of gefitinib, an orally active EGFR-selective tyrosine kinase inhibitor, as a new strategy for treatment of esophageal carcinoma. The effects of gefitinib were evaluated in monotherapy and in combination with radiotherapy in human esophageal carcinoma cell lines. Gefitinib produced a dose-dependent inhibition of cellular proliferation in all of the 8 esophageal carcinoma cell lines examined, with IC50 values ranging from 5.7 microM to 36.9 microM. In combination, gefitinib and radiotherapy showed a synergistic effect in 2 human esophageal carcinoma cell lines and an additive effect in 5 cell lines. Western blotting demonstrated that gefitinib blocked activation of the EGFR-extracellular signal-regulated kinase (Erk) pathway and the EGFR-phosphoinositide-3 kinase (PI3K)-Akt pathway after irradiation. These results suggest that further evaluation of EGFR blockade as a treatment for esophageal cancer should be performed, and that radiotherapy combined with EGFR blockade may enhance the response of esophageal carcinoma to therapy. |
| キーワード | gefitinib esophageal cancer radiosensitivity epidermal growth factor receptor |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-02 |
| 巻 | 60巻 |
| 号 | 1号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 25 |
| 終了ページ | 34 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16508686 |
| Web of Science KeyUT | 000235538900003 |
| JaLCDOI | 10.18926/AMO/30753 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Nakatani, Satoru| Naito, Ichiro| Momota, Ryusuke| Hinenoya, Noriko| Horiuchi, Kanji| Nishida, Keiichiro| Ohtsuka, Aiji| |
| 抄録 | We attempted to prepare colloidal iron within tissues by means of microwave irradiation. Mouse tissue blocks were fixed with a mixture of paraformaldehyde and ferric chloride in a cacodylate buffer, immersed in a cacodylate buffered ferric chloride solution, and irradiated in a microwave processor. Colloidal iron was prepared within tissues or cells, and was observed in the form of electron dense fine granules (1-2 nm in diameter) by transmission electron microscopy. Collagen fibrils in the connective tissue showed colloidal iron deposition at regular periodical intervals. Cells in the splenic tissue showed that fine colloidal granules were deposited on the ribosomes but not on the nuclear chromatin. This finding suggests that ferric ions could not diffuse into the nucleus, which was surrounded by the nuclear envelope. The podocyte processes of the renal glomerulus were stained diffusedly. Though this microwave in situ colloidal iron preparation method has some limitations, it is convenient for use in biomedical specimen preparation in transmission electron microscopy. |
| キーワード | colloidal iron microwave histochemistry transmission electron microscopy |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-02 |
| 巻 | 60巻 |
| 号 | 1号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 59 |
| 終了ページ | 64 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16508690 |
| Web of Science KeyUT | 000235538900007 |
| JaLCDOI | 10.18926/AMO/30751 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Kitajima, Takuji| Nishii, Kenji| Ueoka, Hiroshi| Shibayama, Takuo| Gemba, Kenichi| Kodani, Tsuyoshi| Kiura, Katsuyuki| Tabata, Masahiro| Hotta, Katsuyuki| Tanimoto, Mitsune| Sobue, Tomotaka| |
| 抄録 | To evaluate recent improvements in lung cancer screening, we compared the results of recently conducted lung cancer screening with those of a previous screening. This study compared the survival of lung cancer patients detected by lung cancer screening conducted between 1976 and 1984 (early period) with that conducted between 1989 and 1997 (late period). Two hundred seventy-six patients with lung cancer were detected in the early period and 541 patients with lung cancer were detected in the late period. The median survival time (late : 49.8 vs. early : 27.8 months) and the 5-year survival rate (late : 47.8 vs. early : 34.8%) of the patients with lung cancer detected in the late period were significantly better than those in the early period (p = 0.0054). Among patients undergoing resection, the proportion of pathological stage I patients in the late period was significantly higher than that in the early period (late : 60.8 vs. early : 54.9%, p = 0.005). Multivariate analysis showed that the screening time period was a significant prognostic factor (hazard ratio = 0.685, 95% confidence interval : 0.563-0.832, p = 0.0002). These results were consistent with the findings of case-control studies of lung cancer screening programs in the late period recently conducted in Japan, which also showed a greater efficacy for screening than for previous case-control studies in the early period. |
| キーワード | lung cancer screening survival lung cancer mortality |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 173 |
| 終了ページ | 179 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838046 |
| Web of Science KeyUT | 000238503600005 |
| JaLCDOI | 10.18926/AMO/30750 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Hiraki, Akio| Murakami, Tomoyuki| Aoe, Keisuke| Matsuda, Eisuke| Maeda, Tadashi| Umemori, Yoshiki| Ueoka, Hiroshi| |
| 抄録 | We describe here a patient with a recurrent hemangiopericytoma of the superior mediastinum 23 years after an initial complete resection. In the current biopsy specimen, the tumor cells were much more anaplastic than those seen 23 years ago. Although the patient was treated with chemotherapy, which consisted of ifosfamide and epirubicin, the tumor was unresponsive and he died 6 months later from disease progression. Careful long-term follow-up is mandatory for patients with hemangiopericytomas because recurrence with greater malignancy can develop following an extended disease-free interval. |
| キーワード | primary hemangiopericytoma recurrence mediastinal tumor |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 197 |
| 終了ページ | 200 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838049 |
| Web of Science KeyUT | 000238503600008 |
| JaLCDOI | 10.18926/AMO/30749 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Komiyama, Takamitsu| Nishida, Keiichiro| Yorimitsu, Masanori| Doi, Hideyuki| Miyazawa, Shinichi| Kitamura, Ai| Yoshida, Aki| Nasu, Yoshihisa| Abe, Nobuhiro| Ozaki, Toshifumi| |
| 抄録 | Ossification disturbance in femoral head reportedly is seen in the Spontaneously Hypertensive rats (SHR) between ages of 10 and 20 weeks. We investigated serum and tissue levels of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in SHR relevant to the ossification disturbance and osteonecrosis of the femoral head. Serum levels of IGF-1 and VEGF were significantly lower in SHR than in Wistar Kyoto rats (WKY) at weeks 5, 10, 15 and 20 (p<0.005). The incidence of histological ossification disturbance of the femoral head was higher in SHR (59%) than in WKY (40%) at week 20. Lower serum and local levels of VEGF in SHR appeared to be related to the incomplete ossification of the femoral heads. Immunohistochemical study showed significantly lower numbers of IGF-1 and VEGF positive chondrocytes in the femoral epiphyseal cartilage of SHR than in those of WKY at weeks 10, 15 and 20. Our results suggest that local and/or systemic levels of IGF-1 and VEGF between ages of 5 and 20 weeks might play roles in the pathogenesis of ossifi cation disturbance of the femoral head in SHR. |
| キーワード | spontaneous hypertensive rats insulin like growth factor-1 vascular endothelial growth factor ossification disturbance osteonecrosis |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 141 |
| 終了ページ | 148 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838042 |
| Web of Science KeyUT | 000238503600001 |
| JaLCDOI | 10.18926/AMO/30746 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Matsuo, Toshihiko| |
| 抄録 | We report herein the disappearance of macular hard exudates after the introduction of hemodialysis in diabetic patients. A 62-year-old woman and a 52-year-old man with diabetes mellitus showed hard exudates in the macula of the left eyes. Both patients had previously undergone panretinal photocoagulation in both eyes. During the follow-up, hemodialysis was introduced for deteriorating chronic renal failure caused by diabetic nephropathy. Half a year later, macular hard exudates in the left eyes disappeared dramatically in both patients, but the visual acuity remained the same. No additional laser treatment was done during the observation period. Hemodialysis is considered to have accelerated the resolution of macular hard exudates in both patients. The deposition of macular hard exudates in diabetic patients is due in part to concurrent poor renal function. |
| キーワード | hemodialysis diabetic retinopathy hard exudates macular edema |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 201 |
| 終了ページ | 205 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838050 |
| Web of Science KeyUT | 000238503600009 |
| JaLCDOI | 10.18926/AMO/30745 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Norii, Mika| Yamamura, Masahiro| Iwahashi, Mitsuhiro| Ueno, Akiko| Yamana, Jiro| Makino, Hirofumi| |
| 抄録 | The inflamed synovial tissue (ST) of rheumatoid arthritis (RA) is characterized by the selective accumulation of interferon gamma-producing Th1-type CD4+ T cells. In this study, we investigated whether the predominance of Th1-type CD4+ cells in the ST lesion is mediated by their selective recruitment through Th1 cell-associated chemokine receptors CXCR3 and CCR5. The lymphocyte aggregates in the ST of RA contained a large number of CD4+ T cells, which mostly expressed both CXCR3 and CCR5, but not CCR4. In contrast, the frequencies of CD4+ and CD8+ T cells expressing CXCR3 and CCR5 in the blood were significantly decreased in RA patients, compared with healthy controls (HC), although there was no difference in the frequencies of CCR4-expressing CD4+ and CD8+ T cells between RA and HC. CXCR3, CCR5, and CCR4 expression in blood CD4 + T cells and CXCR3 expression in CD8+ T cells were increased after interleukin-15 (IL-15) stimulation. Therefore, the distribution of Th1-type CD4+ T cells into the ST from the blood in RA may be associated with the local expression of chemokines, both CXCR3 and CCR5 ligands, and IL-15 may play a role in enhancing these chemokine receptors on CD4+ T cell infiltrates. |
| キーワード | CXCR3 CCR5 CD4+ T cells interleukin-15 rheumatoid arthritis |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 149 |
| 終了ページ | 157 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838043 |
| Web of Science KeyUT | 000238503600002 |
| JaLCDOI | 10.18926/AMO/30743 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Sumiyoshi, Hideaki| Matsuo, Noritaka| Shin, Toshitaka| Shirabe, Komei| Yoshioka, Hidekatsu| |
| 抄録 | Type III collagen is found in fetal skin and blood vessels. Previously, we characterized the proximal promoter of the human alpha1(III) collagen gene (COL3A1) using the human rhabdomyosarcoma cell line, A204, and NIH3T3 cells (Yoshino et al., Biochim Biophys Acta, 2005). In the present study, we further analyzed this promoter using additional cell lines, namely a human embryonal rhabdomyosarcoma cell line (RD) and bovine vascular smooth muscle cells (vSMCs), both of which show high expression of type III collagen. Using a luciferase assay, electrophoretic mobility shift assays (EMSA), and DNase footprinting assay, 2 types of multifactor complexes were shown to bind to the DNA region in the vicinity of the B element (- 80 to - 58), depending on the cell type. Next, we used cells stably transfected with a GFP-linked type III collagen promoter fragment for analysis of promoter expression. Usually, transfected cells retained the characteristics of the original cells. However, in several clones derived from RD cells, promoter expression as well as cell shape changed to patterns characteristic of the A204 cell line. Nuclear factors expressed by these clones were also characteristic of the A204 line. |
| キーワード | type III collagen promoter transcription DNA binding protein |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-06 |
| 巻 | 60巻 |
| 号 | 3号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 181 |
| 終了ページ | 189 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16838047 |
| Web of Science KeyUT | 000238503600006 |
| JaLCDOI | 10.18926/AMO/30742 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Tajiri, Takuma| Tate, Genshu| Iwaku, Takeshi| Takeyama, Nobuyuki| Fusama, Shigeyoshi| Sato, Shuichi| Kunimura, Toshiaki| Mitsuya, Toshiyuki| Morohoshi, Toshio| |
| 抄録 | Right pleural effusion was diagnosed in a 36-year-old woman with right upper quadrant pain and fever. Enhanced pelvic computed tomography performed because of irregular genital bleeding revealed the pelvic inflammatory disease. Upon further questioning, the patient confirmed that she had recently undergone therapy for Chlamydia trachomatis infection. Therefore she was given an injection of tetracycline because we suspected Fitz-Hugh-Curtis syndrome (FHCS), a pelvic inflammatory disease characterized by perihepatitis associated with chlamydial infection. A remarkable clinical response to antibiotics was noted. The right upper quadrant pain was due to perihepatitis, and the final diagnosis was FHCS. Right pleural effusion may be caused by inflammation of the diaphragm associated with perihepatitis. Once chlamydial infection reaches the subphrenic liver, conditions in the closed space between the liver and diaphragm due to inflammatory adhesion may be conductive to chlamydial proliferation. The possibility of FHCS should be considered in patients and carefully distinguished from other abdominal diseases. |
| キーワード | perihepatitis right pleural eff usion Fitz-Hugh-Curtis syndrome chlamydial infection pelvic inflammatory disease |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 289 |
| 終了ページ | 294 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072375 |
| Web of Science KeyUT | 000241509000005 |
| JaLCDOI | 10.18926/AMO/30741 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Nagasaka, Takeshi| Goel, Ajay| Matsubara, Nagahide| Tanaka, Noriaki| |
| 抄録 | Aberrant promoter methylation, an 'epigenetic' form of genomic instability that leads to transcriptional silencing of tumor suppressor genes, is increasingly being recognized as a crucial component in the evolution of human cancers. With our limited knowledge of the molecular basis and timing of the initiation of altered methylation events in the stepwise progression of cancers, the biggest challenge we currently face is to identify novel biomarkers and technologies for the timely screening of patients carrying such alterations. One such strategy would be to develop tests for the detection of fecal DNA methylation patterns that will improve the sensitivity of noninvasive screening tests for colorectal neoplasia, and moreover, will decrease both mortality and the incremental costs of treating colorectal cancers. |
| キーワード | fecal DNA colorectal cancer methylation epigenetics |
| Amo Type | Review |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 249 |
| 終了ページ | 256 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072371 |
| Web of Science KeyUT | 000241509000001 |
| JaLCDOI | 10.18926/AMO/30740 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Une, Tomoka| Yokoyama, Yuji| Ninomiya, Shinsuke| Shinozuka, Masako| Maruyama, Hidehiko| Morishima, Tsuneo| |
| 抄録 | Some marker chromosomes and chromosome rearrangements are difficult to identify using G-bands by Giemsa staining after trypsin treatment (G-banding) alone. Molecular cytogenetic techniques, such as spectral karyotyping (SKY) and fluorescence in situ hybridization (FISH), can help to detect chromosomal aberrations precisely. We analyzed the karyotypes in 6 cases of multiple congenital abnormalities and 1 case of spontaneous abortion (case 2). Three cases (cases 1, 6, and 7) had marker chromosomes, and 4 cases (cases 2-5) had chromosomal rearrangements. The karyotypes in cases 1, 2, and 3 were determined using FISH with probes based on the clinical findings and family histories. Spectral karyotyping (SKY) analysis in cases 4-7 showed that this method is useful and saves time. The combination of SKY and FISH analyses defi ned the range of the ring chromosome in case 7. We demonstrated that a combination of G-banding, FISH, and SKY can be applied effectively to the investigation of chromosomal rearrangement and to the detection of marker chromosome origins. We suggest the use of these methods for prenatal diagnosis, in which the inherent time limitations are particularly important. |
| キーワード | spectral karyotyping fluorescence in situ hybridization molecular cytogenetics marker chromosome chromosome rearrangement |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 279 |
| 終了ページ | 287 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072374 |
| Web of Science KeyUT | 000241509000004 |
| JaLCDOI | 10.18926/AMO/30739 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Aiga, Ayako| Asaumi, Koji| Lee, You Jin| Kadota, Hiroaki| Mitani, Shigeru| Ozaki, Toshifumi| Takigawa, Masaharu| |
| 抄録 | The localization and expression of neurotrophins and their receptors during distraction osteogenesis was investigated in 72 male rat femurs (11 weeks old) to further clarify the concurrence of cellular and molecular events of new bone formation. After osteotomy, a 7-day lag phase was followed by distraction at the rate of 0.25 mm/12 h for 21 days (distraction phase), and a 7-day consolidation phase. The localization of neurotrophins (NGF, BDNF and NT-3) and their receptors tropomyosinrelated kinases (TRKA, TRKB and TRKC) by immunostaining showed positive staining in bone forming cells in each stage, although the presence and staining intensity varied by cell type and phase. The expressions of NGF, BDNF and NT-3 by real-time polymerase chain reaction (real-time PCR) showed that the peak of the mRNA expression of NGF occurred 10 days after distraction. NT-3 increased during bone extension, but decreased when distraction stopped. In contrast, BDNF continued to increase gradually throughout the distraction and consolidation phases. These findings suggest that neurotrophins and their receptors may play different roles in endochondral and intramembranous ossification in distraction osteogenesis. The tension stress caused by distraction may stimulate the expression of neurotrophins and their receptors, and promote osteogenesis. |
| キーワード | neurotrophin Trk distraction osteogenesis mechanical stress |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 267 |
| 終了ページ | 277 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072373 |
| Web of Science KeyUT | 000241509000003 |
| JaLCDOI | 10.18926/AMO/30738 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Ohtani, Yuu| Aoe, Motoi| Hara, Fumikata| Tao, Hiroyuki| Koshimune, Ryuichiro| Hirami, Yuuji| Hanabata, Tetsuro| Shimizu, Nobuyoshi| |
| 抄録 | To investigate the suppressive effect of human recombinant TIMP-1 (rh-TIMP-1) on tumor proliferation using an in vivo xenograft system, HT29 was suspended in 0.1 ml phosphate buffered saline (PBS) and then subcutaneously injected in the back of female mice (BALB/C nu/nu). The mice were divided into 2 groups an and the tumor diameter was measured after rh-TIMP-1 (2 mg/kg) (rh-TIMP-1 group) or PBS (control group) was administered injections according to the following schedules. Schedule 1 : Beginning 2 weeks after the subcutaneous injection of HT29, an intraperitoneal injection of rh-TIMP-1 or PBS were performed twice a day (every 12 h) for 14 consecutive days. Schedule 2 : Beginning 1 week after the subcutaneous injection of HT29, an intraperitoneal injection was performed twice a day for 14 consecutive days. Schedule 3 : Intraperitoneal injections were started simultaneously with the subcutaneous injection of HT29, and then performed twice a day for 21 consecutive days. The mice were sacrificed and the tumors extirpated for immunohistochemical investigation. In addition, gelatin zymography and a cell proliferation assay were performed. With Schedule 1, the changes in the tumor diameter in the rh-TIMP-1 group followed the same course as those in the control group, and no suppressive effect on tumor proliferation was observed. However, with Schedule 3, a remarkable suppressive effect was observed throughout the treatment period. In immunostaining, more cases negative for MMP-9 were observed in the rh-TIMP-1 group than in the control group. Cases negative for CD34 were significantly more observed in the rh-TIMP-1 group than in the control group with Schedule 3. All of the results were obtained through the suppressive effect of rh-TIMP-1 on angiogenesis. |
| キーワード | MMP-2 MMP-9 TIMP-1 molecular targeting therapy angiogenesis |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 257 |
| 終了ページ | 266 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072372 |
| Web of Science KeyUT | 000241509000002 |
| JaLCDOI | 10.18926/AMO/30737 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Suzaki, Noriyuki| Hiraki, Akio| Takigawa, Nagio| Ueoka, Hiroshi| Tanimoto, Yasushi| Kozuki, Toshiyuki| Tabata, Masahiro| Kanehiro, Arihiko| Kiura, Katsuyuki| Tanimoto, Mitsune| |
| 抄録 | A 71-year-old Japanese man with adenocarcinoma of the lung developed interstitial pneumonia after treatment with paclitaxel. The patient had acute chills and fever on the fourth day after the second exposure to paclitaxel, rapidly got worse despite empiric therapies, and developed prolonged respiratory failure requiring mechanical ventilation. Four months later, he died of respiratory failure due to progression of both interstitial pneumonia and lung cancer. This is the first case developing fatal paclitaxel-induced pulmonary toxicity to date. Interstitial pneumonia should be considered one of the possible life-threatening complications during treatment with paclitaxel. |
| キーワード | paclitaxel adverse effect lung cancer interstitial pneumonia |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-10 |
| 巻 | 60巻 |
| 号 | 5号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 295 |
| 終了ページ | 298 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 17072376 |
| Web of Science KeyUT | 000241509000006 |
| JaLCDOI | 10.18926/AMO/30735 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Alptekin, Davut| Luleyap, Husnu Umit| Yilmaz, Levent| Demirhindi, Hakan| Gokel, Yuksel| Pazarbasi, Ayfer| Dokur, Mehmet| Kasap, Mulkiye| Kasap, Halil| |
| 抄録 | This study included 45 patients with intentional insecticide intoxication and 21 with accidental intoxication who were treated at the First-Aid and Emergency Department of Balcali Hospital at the Faculty of Medicine in the Cukurova University, Adana, Turkey, while the control group consisted of 25 people selected from university personnel known to be healthy. Patients with a history of X-ray exposure in the last 6 months or of any virus disease as well as continuous drug users and smokers were excluded, leaving a total of 49 patients. Acetylcholine esterase (Pseudocholinesterase) enzyme (AchE), sister-chromatid exchanges (SCE), the mitotic index (MI), and the replication index (RI) were evaluated. Blood samples were cultured for SCE evaluation and sera separated for AchE levels. Insecticide exposure was generally intentional for suicide in adolescents and at older ages, but accidental for children. AchE levels were found to be significantly lower in organophosphorus (OP) and carbamated (CB) insecticide poisoning groups in comparison with the control group (p<0.001), while the pyrethroid (PY) group was not statistically different for the AchE effect (p>0.05). SCE was found to be significantly higher in OP and CB groups (p<0.001), while the PY and control groups were statistically similar for SCE levels (p>0.05). This study showed an increase in SCE in response to orally ingested insecticides. These findings indicate that insecticide exposure results in cell abnormalities, with resulting impediments to the division and replication of cells, as suggested by MI decreases and RI increases, while the speed of the division cycles of stimulated cells increases. |
| キーワード | insecticide intoxication acetylcholine esterase enzyme (AchE) sister-chromatid exchanges (SCE) |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 121 |
| 終了ページ | 126 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16680189 |
| Web of Science KeyUT | 000237001900008 |
| JaLCDOI | 10.18926/AMO/30734 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Sugimoto, Seiichiro| Doihara, Hiroyoshi| Ogasawara, Yutaka| Aoe, Motoi| Sano, Shunji| Shimizu, Nobuyoshi| |
| 抄録 | A 61-year-old man, who was diagnosed with superior vena cava syndrome by papillary thyroid carcinoma, was referred to our hospital. A bulky thyroid tumor with tracheal invasion extended from the left neck to the right atrium without distant metastases. The risk of sudden death due to airway occlusion, tumor embolism or obstruction of the tricuspid valve led us to elect surgery. Extended resection of thyroid cancer was performed with cardiopulmonary bypass. Peritoneal dissemination was found via laparotomy. A histological diagnosis of anaplastic carcinoma arising from transformation of papillary carcinoma was made. After the operation, bilateral ureteral occlusion by peritoneal dissemination and multiple lung metastases were detected. The patient died with acute renal failure on postoperative day 12. Intraatrial extension of thyroid cancer is rare, and only 12 cases have been reported in the literature. We present a case of thyroid cancer with intraatrial extension. |
| キーワード | superior vena cava syndrome thyroid cancer cardiopulmonary bypass |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 135 |
| 終了ページ | 140 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16680191 |
| Web of Science KeyUT | 000237001900010 |
| JaLCDOI | 10.18926/AMO/30733 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Noguchi, Hirofumi| Matsumoto, Shinichi| Matsushita, Masayuki| Kobayashi, Naoya| Tanaka, Koichi| Matsui, Hideki| Tanaka, Noriaki| |
| 抄録 | The development by the Edmonton group of a sirolimus-based, steroid-free, low-tacrolimus regimen is a significant breakthrough that allows the rate of insulin independence after islet transplantation to increase from 13% to 80% at 1 year ; however, the rate is reduced to 50% at 3 years, attributed to prolonged tacrolimus exposure. Recently, immunosuppression agents such as cyclosporine, mycophenolate mofetil, and the novel agent FTY 720 have been used instead of tacrolimus. Lymphocytedepleting antibodies such as anti-thymocyte globulin, alemtuzumab, and hOKT3gamma 1 (ala, ala) have been launched, and a costimulatory blockade of anti-CD40 monoclonal antibodies and CTLA4-Ig will be attempted in the near future. Moreover, the potential of a novel immunosuppressing peptide could now be realized using new technology called the protein transduction system. In this review, we show some of the most recent contributions to the advancement of knowledge in this field. |
| キーワード | islet transplantation steroid-free Edmonton protocol protein transduction syst |
| Amo Type | Review |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 71 |
| 終了ページ | 76 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16680182 |
| Web of Science KeyUT | 000237001900001 |
| JaLCDOI | 10.18926/AMO/30731 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Mukai, Takashi| Sato, Shuhei| Iguchi, Toshihiro| Mimura, Hidefumi| Yasui, Kotaro| Gobara, Hideo| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| Kanazawa, Susumu| |
| 抄録 | We quantitatively evaluated total and individual renal function by technetium-99m mercaptoacetyltriglycine (Tc-99m MAG3) renal scintigraphy before and after radiofrequency ablation (RFA) of renal tumors. Eleven patients who underwent Tc-99m MAG3 renal scintigraphy 1 week before and after RFA were evaluated (7 men and 4 women ; age range : 23-83 years ; mean age : 60.6 years). Five patients had solitary kidneys, and five had normally or minimally functioning contralateral kidneys. One patient had a renal cell carcinoma in the contralateral kidney. One patient with a solitary kidney underwent RFA a second time for a residual tumor. In patients with a solitary kidney, MAG3 clearance decreased after 5 of 6 RFAs, and in patients with a normally functioning contralateral kidney, MAG3 clearance decreased after 4 of 5 RFAs, but no significant differences were observed between before and after treatments. In addition to the total MAG3 clearance, the split MAG3 clearance was evaluated in patients with a normally functioning contralateral kidney. MAG3 clearance decreased in 4 of 5 treated kidneys, while it adversely increased in the contralateral kidneys after 4 of 5 RFAs. No significant differences, however, were observed between before and after treatments. The results of our study revealed no significant differences in sCr, BUN, CCr, or MAG3 clearance between pre- and post-RFA values. These results support data regarding the functional impact and safety of renal RFA in published reports. We evaluated total and individual renal function quantitatively using Tc-99m MAG3 renal scintigraphy before and after treatment. This scintigraphy was very useful in assessing the effects of RFA on renal function. |
| キーワード | kidney renal tumor radiofrequency ablation Tc-99m MAG3 renal scintigraphy individual renal function |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 85 |
| 終了ページ | 91 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| Web of Science KeyUT | 000237001900003 |
| JaLCDOI | 10.18926/AMO/30730 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Arai, Meiji| Kosuge, Kazuko| Kawamoto, Fumihiko| Matasuoka, Hiroyuki| |
| 抄録 | Deficiency of glucose-6-phosphate dehydrogenase (G6PD) causes acute hemolytic anemia triggered by oxidative drugs such as primaquine. It is therefore essential in malaria-endemic areas for malaria patients to be confirmed for their G6PD activity before taking primaquine. The WST-8 method, a newly established screening method for G6PD deficiency, has been demonstrated to be suitable for field conditions, particularly for on-site malaria surveys. Here we report a laboratory evaluation by this method of the reactivity of blood-spotted filters. A time-course experiment was conducted to evaluate the reactivity of blood samples spotted onto 4 types of filter paper, Whatman 31ET Chr (ET), 3MM Chr (3MM), P81, and Advantec No. 2 (AD2). The rank of the relative reaction intensity was ET > 3MM = AD2 > P81. Blood-spotted filters stored at 4 degrees centigrade gradually decreased G6PD reactivity with the passage of storage time, whereas those stored at room temperature rapidly reduced their reactivity. Unexpectedly, saponin supplementation reduced the reactivity of blood-spotted filters. In conclusion, 1) ET is the most suitable filter for the WST-8 method ; 2) blood-spotted filters stored in cold condition can be assayed within 14 days, or those stored at room temperature should be tested within 3 days ; and 3) reaction mixtures should not contain saponin. |
| キーワード | glucose-6-phosphate dehydrogenase G6PD deficiency blood-spotted filter WST-8 method malaria |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 127 |
| 終了ページ | 134 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16680190 |
| Web of Science KeyUT | 000237001900009 |
| JaLCDOI | 10.18926/AMO/30729 |
|---|---|
| フルテキストURL | fulltext.pdf |
| 著者 | Ohta, Takeyuki| Sakaguchi, Kohsaku| Fujiwara, Akiko| Fujioka, Shin-ichi| Iwasaki, Yoshiaki| Makino, Yasuhiro| Araki, Yasuyuki| Shiratori, Yasushi| |
| 抄録 | This study was conducted to develop a simple surrogate index comprised of routinely available laboratory tests to reflect the histological fibrosis stage. Clinical characteristics and laboratory data from 368 and 249 consecutive patients with chronic hepatitis C, a training cohort and a validation cohort, respectively, were retrospectively evaluated. Platelet (Plt) count and albumin (Alb) level contributed to the discrimination of the respective fibrosis stages. We derived the fi brosis index (FI), FI = 8.0-0.01 x Plt (10 multiply 3/microliter) - Alb (g/dl), from a multiple regression model. FI significantly correlated with the histological fibrosis stage in both the initial and validation cohort at p=0.691 and p=0.661, respectively (Spearman's rank correlation coefficient, p<0.0001). The sensitivity and positive predictive value of FI at a cutoff value < 2.10 for predicting fibrosis stage F0-1 were 66.8% and 78.8% in the initial cohort and 68.5% and 63.6% in the validation cohort, respectively. Corresponding values of FI at a cutoff value >- 3.30 for the prediction of F4 were 67.7% and 75.0% in the initial cohort and 70.8% and 81.0% in the validation cohort. The fibrosis index comprised of platelet count and albumin level reflected the histological fibrosis stage in patients with chronic hepatitis C. |
| キーワード | albumin level chronic hepatitis C fi brosis index fi brosis stage platelet count |
| Amo Type | Article |
| 出版物タイトル | Acta Medica Okayama |
| 発行日 | 2006-04 |
| 巻 | 60巻 |
| 号 | 2号 |
| 出版者 | Okayama University Medical School |
| 開始ページ | 77 |
| 終了ページ | 84 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| 資料タイプ | 学術雑誌論文 |
| 言語 | 英語 |
| 論文のバージョン | publisher |
| 査読 | 有り |
| PubMed ID | 16680183 |
| Web of Science KeyUT | 000237001900002 |